[Meningitis caused by Pseudomonas aeruginosa. Treatment with meropenem].
J
J
Barberán
M C
MC
García
A
A
Campos
S
S
Khorrami
D000368:Aged; D001812:Blood-Brain Barrier; D000077723:Cefepime; D002439:Cefotaxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002557:Cerebrospinal Fluid Shunts; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D006849:Hydrocephalus / Q000150:complications / Q000601:surgery; D008297:Male; D016920:Meningitis, Bacterial / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology*; D000077731:Meropenem; D011183:Postoperative Complications / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D013845:Thienamycins / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D002511:Cephalosporins; D013845:Thienamycins; D000077723:Cefepime; D000077731:Meropenem; D002439:Cefotaxime